APEXXX Supplements for Male Sexual Enhancement Recalled

Nuway Distributors is voluntarily recalling all lots of APEXXX tablets, a dietary supplement marketed for male sexual enhancement.

The FDA released a press release about the voluntary recall, which was catalyzed by an analysis that found sildenafil in the supplements.

The discovery of the PDE-5 inhibitor, which is used for erectile dysfunction, made the supplement a tainted, unapproved drug.

Sildenafil, which was not listed on the APEXXX label, can interact with nitrates found in some drugs such as nitroglycerin and can dangerously lower blood pressure.

Adverse effects of sildenafil include headaches and flushing.

All lots of the drug sold between 2014 and June 2015 are being recalled.

APEXXX can be identified by its black packaging and its yellow diamond-shaped tablet, which has “APEXXX” listed on it.

Nuway Distributors is also recalling all lots of its OPAL tablets, also marketed for male sexual enhancement, because the product was sourced from the same vendors as the APEXXX tablets.

Consumers and retailers who own these products should stop using them or selling them and should contact Nuway Distributors to arrange a return.

Additionally, the FDA is asking the public to report adverse effects to its MedWatch Adverse Event Reporting program online, by mail, or via fax.